Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,045 | 562 | 99.0% |
| Education | $89.16 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,677 | 195 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $883.66 | 56 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $634.74 | 35 | $0 (2024) |
| Celgene Corporation | $426.05 | 29 | $0 (2024) |
| Janssen Biotech, Inc. | $385.04 | 23 | $0 (2024) |
| Medtronic, Inc. | $324.51 | 4 | $0 (2024) |
| Gilead Sciences, Inc. | $311.51 | 13 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $266.93 | 11 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $232.71 | 12 | $0 (2017) |
| IRONWOOD PHARMACEUTICALS, INC | $229.44 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,638 | 86 | ABBVIE INC. ($531.87) |
| 2023 | $1,554 | 84 | ABBVIE INC. ($407.21) |
| 2022 | $1,540 | 90 | ABBVIE INC. ($596.65) |
| 2021 | $967.68 | 69 | AbbVie Inc. ($447.05) |
| 2020 | $316.13 | 17 | AbbVie Inc. ($90.64) |
| 2019 | $981.94 | 60 | AbbVie, Inc. ($278.02) |
| 2018 | $1,095 | 66 | Aries Pharmaceuticals, Inc. ($181.43) |
| 2017 | $1,042 | 92 | Valeant Pharmaceuticals North America LLC ($232.71) |
All Payment Transactions
564 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: LIVER DISEASE | ||||||
| 12/18/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: VIROLOGY | ||||||
| 12/16/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $5.44 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: VIROLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $9.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $2.48 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/31/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/30/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $133.42 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Immunology | ||||||
| 10/22/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/17/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Immunology | ||||||
| 10/10/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $23.05 | General |
| Category: GI | ||||||
| 10/09/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/08/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Gastroenterology | ||||||
| 10/07/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: LIVER DISEASE | ||||||
| 10/02/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: VIROLOGY | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 258 | 285 | $59,720 | $14,204 |
| 2022 | 13 | 360 | 467 | $101,513 | $27,306 |
| 2021 | 17 | 546 | 685 | $155,473 | $37,784 |
| 2020 | 11 | 479 | 518 | $153,495 | $38,005 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 77 | $17,517 | $6,157 | 35.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 27 | 27 | $20,250 | $2,839 | 14.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 45 | $7,110 | $2,498 | 35.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $11,250 | $1,262 | 11.2% |
| 91200 | Measurement of liver stiffness | Office | 2023 | 28 | 28 | $2,100 | $590.72 | 28.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 31 | 35 | $385.00 | $294.00 | 76.4% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 15 | 15 | $375.00 | $200.40 | 53.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 12 | 14 | $252.00 | $144.90 | 57.5% |
| 83550 | Iron binding capacity | Office | 2023 | 15 | 15 | $285.00 | $128.55 | 45.1% |
| 83540 | Iron level | Office | 2023 | 14 | 14 | $196.00 | $88.76 | 45.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 68 | 134 | $17,956 | $8,538 | 47.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 73 | 87 | $19,575 | $7,657 | 39.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 15 | 16 | $12,000 | $2,982 | 24.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 32 | 33 | $24,750 | $2,483 | 10.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 22 | 23 | $17,250 | $2,135 | 12.4% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2022 | 11 | 11 | $3,245 | $999.85 | 30.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 18 | 21 | $1,113 | $741.93 | 66.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $2,600 | $728.71 | 28.0% |
| 91200 | Measurement of liver stiffness | Office | 2022 | 23 | 23 | $1,725 | $454.19 | 26.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 20 | 25 | $450.00 | $260.30 | 57.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 15 | 18 | $252.00 | $137.78 | 54.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 37 | 47 | $517.00 | $136.26 | 26.4% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 13 | 16 | $80.00 | $51.84 | 64.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 95 | 181 | $23,741 | $12,435 | 52.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 77 | 96 | $21,720 | $8,949 | 41.2% |
About Dr. Radha Menon, M.D
Dr. Radha Menon, M.D is a Gastroenterology healthcare provider based in High Point, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2008. The National Provider Identifier (NPI) number assigned to this provider is 1427218122.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Radha Menon, M.D has received a total of $9,134 in payments from pharmaceutical and medical device companies, with $1,638 received in 2024. These payments were reported across 564 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($9,045).
As a Medicare-enrolled provider, Menon has provided services to 1,643 Medicare beneficiaries, totaling 1,955 services with total Medicare billing of $117,298. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location High Point, NC
- Active Since 06/16/2008
- Last Updated 09/25/2024
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1427218122
Products in Payments
- MAVYRET (Drug) $767.37
- XIFAXAN (Drug) $597.77
- LINZESS (Drug) $580.94
- DUPIXENT (Biological) $454.20
- ZEPOSIA (Drug) $441.90
- RINVOQ (Biological) $403.78
- Humira (Biological) $401.73
- INTERSTIM (Device) $324.51
- Entyvio (Biological) $271.80
- TRULANCE (Drug) $230.23
- INJECTAFER (Drug) $226.21
- STELARA (Biological) $221.02
- ENTYVIO (Biological) $218.71
- ELEVIEW (Device) $181.43
- VOQUEZNA (Drug) $172.26
- ZENPEP (Drug) $170.23
- Linzess (Drug) $168.75
- Sucraid (Drug) $158.84
- Amitiza (Drug) $155.09
- VIBERZI (Drug) $153.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in High Point
Albert Rhoton, Md, MD
Gastroenterology — Payments: $137,213
Shabana Shahid, M.d, M.D
Gastroenterology — Payments: $27,647
John Walker, Md, MD
Gastroenterology — Payments: $5,615
Dr. Rajesh Gupta, Md, MD
Gastroenterology — Payments: $2,010
Christopher Benson, M.d, M.D
Gastroenterology — Payments: $203.95
Tri Le, Md, MD
Gastroenterology — Payments: $76.89